Cardiac Safety Services Market Size To Reach USD 895.7 Million by 2026 | Top Key Players Biotrial, Banook Group, Bioclinica

The rising incidences of Cardiovascular disorders, improved technological advances, rising prevalence of heart related diseases, rising geriatric population, new product launches, and strategic collaboration, are key factors contributing to the high CAGR of the Cardiac Safety Services market during the forecast period.

According to the current analysis of Reports and Data, the global Cardiac Safety Services Market valued at USD 384.9 million in 2018 and is expected to reach USD 895.7 million by the year 2026, at a CAGR of 11%. Cardiac safety is the primary cause of the Clinical trial delay and drug abandonment. Cardiac Safety services are beneficial for monitoring the abnormalities of the heart. There has been a significant rise in the R&D expenditure in the pharmaceutical & biopharmaceutical industry and increased R&D activities. The increase in the number of clinical trials is fuelling the growth of the market. Additionally, the advances of the new technologies in the cardiac services market are offering growth opportunities for players in the market. However, the high expenditure cost of cardiac safety evaluation is hindering the growth of the market.

American college of cardiology has reported in the year 2019 that Cardiovascular disease (CVD) is the primary cause of death in the United States and is responsible for 840,768 deaths in 2016. From 2006 - 2016, the U.S. death rate from cardiovascular disorders have decreased by 18.6% and from coronary heart disease by 31.8%.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2707

Technological advancements and rapid digitization have streamlined the daily operations of the pharmaceutical industry. Increasing spending on medicine due to growing geriatric populace, rising incidence of chronic diseases, increasing number of product launches, and growing number of R&D activities are some key factors contributing to revenue growth of the market. Increasing focus on patient engagement solutions, rising focus to cater to growing unmet clinical demand, adoption of advanced technologies to streamline workflows in healthcare sector, and availability of skilled healthcare professionals has been positively impacting the pharma & healthcare industry. The emergence of COVID-19 pandemic has further increased focus on healthcare facilities, teleconsultation and telemedicine, and increased burden on the healthcare industry compelling governments and companies to invest heavily to cater to the growing global demand.

Further key findings from the report suggest

• Microsoft had launched Microsoft Hololens; it enables the measurement and visualization of blood flow. Microsoft Hololens do not require any tethering device or any additional hardware. The system includes a front-facing camera, remote imaging photoplethysmography software; it allows the users to view the physiological state of a person by simply looking at them. The blood Flow is measured by just looking at the appearance of the subject.

• Acoalition of professional societies had developed the AUC (Appropriate use criteria) for cardiac imaging to standardize the cardiac imagining system for patients with congenital heart disease it was developed by the American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography, and the International Society for Adult Congenital Heart Disease, AUC provides guidelines to the clinicians to understand the relative risks and benefits of various cardiovascular procedures it also guidelines to understand the risk tetralogy of Fallot, transposition, or atrial septal defects

• ERT in the year 2018 had launched a Cardiac Safety Center and is also the first to do it; they offer cardia safety assessment in Phase 1 studies using integrated ECG analysis. They had used the Icardiac Technologies for obtaining a precise ECG data using an ERT Expert technology platform.

• ECG or Holter monitors in the product and service segment have obtained the largest share in the year 2018 of about 31.5% due to an increase in the rise of cardiac disorders in individuals and easy monitoring by these devices.

• North America in the region has obtained an exceptional share due to better healthcare facilities, improved clinical trials, and also due to the prevalence of the incidences of cardiovascular disorders and also due to the presence of major pharmaceutical & biopharmaceutical companies in the region.

• Biotrial (France), Banook Group (France & Canada), Bioclinica (a subsidiary of Cinven, US), Certara L.P. (U.S.), Celerion, Inc. (U.S.), ERT, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Medpace Holdings, Inc. (U.S.), Ncardia AG (Belgium), Richmond Pharmacology (U.K.), PhysioStim (France), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development LLC (U.S.), SGS S.A. (Switzerland), BioTelemetry, Inc. (U.S.), IQVIA (U.S.), OMRON Healthcare, Inc (Japan), Biobeat (U.S.) and InBody USA (U.S.), Microsoft (U.S.) are the key players in the Cardiac Safety Services market

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2707

For the purpose of this purpose, Reports and Data have segmented the Cardiac Safety Services market on the basis of product and service, applications, end use and region.

Product and Services Outlook (Revenue in Million USD; 2017–2026)

• ECG/Holter Measurement
• Blood Pressure Measurement
• Cardiovascular Imaging
• Thorough Q.T. Studies
• Other Services

Applications Outlook (Revenue in Million USD; 2017–2026)

• Integrated Services
• Standalone Services

End Use Outlook (Revenue in Million USD; 2017–2026)

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Research Organizations

Regional Outlook (Revenue in Million USD; 2017–2026)

• North America
o U.S
o Canada
• Europe
o Germany
o France
o UK
o Spain
o Italy
o Rest of the Europe
• Asia Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• Middle East & Africa
• Latin America
o Brazil

In conclusion, the report offers a comprehensive analysis of the factors expected to drive the global Cardiac Safety Services market growth over the forecast period of 2021-2026. The report is an all-inclusive document covering the market landscape and a futuristic perspective on its growth and progress. The report also provides an analysis of the entry-level driving and restraining factors for the new entrants contributing to the market. The report also offers strategic recommendations to the established players as well as new entrants to help them gain a strong foothold in the market.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2707

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Read More Reports:-

Needle Free Injection Systems Market @ https://www.google.com.ua/url?q=https://www.reportsanddata.com/report-detail/needle-free-injection-systems-market

Cerebral Thrombectomy Systems Market @ https://www.google.co.ve/url?q=https://www.reportsanddata.com/report-detail/cerebral-thrombectomy-systems-market

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.